Cost-effectiveness of lung cancer screening with CT-scan

H. De Koning (Rotterdam, Netherlands)

Source: Virtual Congress 2020 – Frontiers of lung cancer screening
Session: Frontiers of lung cancer screening
Session type: Joint session
Number: 3736

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. De Koning (Rotterdam, Netherlands). Cost-effectiveness of lung cancer screening with CT-scan. Virtual Congress 2020 – Frontiers of lung cancer screening

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Update on lung cancer screening with low-dose CT
Source: Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening
Year: 2021


Screening for lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=71
Year: 2001

Factors determining early adherence to a lung cancer screening protocol
Source: Eur Respir J 2007; 30: 532-537
Year: 2007



Towards personalized lung cancer CT screening in Europe
Source: Virtual Congress 2020 – Screening and imaging in lung cancer
Year: 2020




The evidence on CT: lung cancer screening
Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice
Year: 2018

Role of CT guided lung biopsy in the diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 65s
Year: 2001

Missed lung cancer on chest radiography – does it affect the outcome?
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007



Combining bronchoscopy and PET for assessment and staging of lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 678s
Year: 2005

Low-dose chest computed tomographic screening and invasive diagnosis of pulmonary nodules for lung cancer in never-smokers
Source: Eur Respir J, 56 (5) 2000177; 10.1183/13993003.00177-2020
Year: 2020



Screening and diagnosis of lung cancer
Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer
Year: 2013


Bronchoscopic techniques in diagnosis and staging of lung cancer
Source: Breathe 2011; 7: 324-337
Year: 2011

Cost-effectiveness analysis of home-based rehabilitation in inoperable lung cancer
Source: Virtual Congress 2021 – A selection of the best abstracts in respiratory physiotherapy and exercise
Year: 2021



Linear endobronchial ultrasonography for diagnosis and staging of lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 594s
Year: 2006

Implementation of EUS-FNA for lung cancer staging
Source: Eur Respir J 2007; 30: Suppl. 51, 109s
Year: 2007

Improving lung cancer staging with EUS-FNA
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009

Prevalence of COPD in a lung cancer screening programme with low dose CT scan
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009

Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


PET/CT of lung cancer
Source: International Congress 2018 – PG4 Imaging of the chest
Year: 2018